Pulmonary Fibrosis Treatment Market Size

Pulmonary Fibrosis Treatment Market size was over USD 3.06 billion in 2023 and is anticipated to cross USD 6.69 billion by 2036, witnessing more than 6.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of pulmonary fibrosis treatment is estimated at USD 3.21 billion.

As per the Pulmonary Fibrosis Foundation, the disease affects about 1 out of 200 adults above the age of 70 years in the United States. Moreover, around 50,000 new cases of pulmonary fibrosis are diagnosed in the country every year.